Imagion Biosystems Ltd (IBX) - Cash Flow Conversion Efficiency

Latest as of December 2025: 1.048x

Based on the latest financial reports, Imagion Biosystems Ltd (IBX) has a cash flow conversion efficiency ratio of 1.048x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-2.27 Million ≈ $-1.60 Million USD) by net assets (AU$-2.16 Million ≈ $-1.53 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Imagion Biosystems Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Imagion Biosystems Ltd - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Imagion Biosystems Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Imagion Biosystems Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Imagion Biosystems Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Weststar Industrial Ltd AU:WSI	-0.175x
Samfine Creation Holdings Group Limited NASDAQ:SFHG	0.035x
PURE ENERGY MINLS F:AHG	0.000x
SVP GLOBAL TEXTILES LIMITED NSE:SVPGLOB	-0.001x
Brilliant Future AB ST:BRILL	-0.207x
GB Group plc LSE:GBG	0.047x
Northern Shield Resources Inc. V:NRN	-0.115x
Azevedo & Travassos S.A SA:AZEV3	0.195x

Annual Cash Flow Conversion Efficiency for Imagion Biosystems Ltd (2014–2025)

The table below shows the annual cash flow conversion efficiency of Imagion Biosystems Ltd from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see IBX company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	AU$-2.16 Million ≈ $-1.53 Million	AU$-4.04 Million ≈ $-2.86 Million	1.870x	+236.07%
2024-12-31	AU$-2.28 Million ≈ $-1.62 Million	AU$-1.27 Million ≈ $-899.04K	0.557x	-74.65%
2023-12-31	AU$-3.79 Million ≈ $-2.68 Million	AU$-8.32 Million ≈ $-5.88 Million	2.195x	+227.18%
2022-12-31	AU$4.68 Million ≈ $3.31 Million	AU$-8.07 Million ≈ $-5.71 Million	-1.726x	-353.14%
2021-12-31	AU$13.31 Million ≈ $9.41 Million	AU$-5.07 Million ≈ $-3.59 Million	-0.381x	-6.41%
2020-12-31	AU$12.91 Million ≈ $9.14 Million	AU$-4.62 Million ≈ $-3.27 Million	-0.358x	+74.55%
2019-12-31	AU$2.97 Million ≈ $2.10 Million	AU$-4.18 Million ≈ $-2.96 Million	-1.406x	+33.10%
2018-12-31	AU$3.87 Million ≈ $2.74 Million	AU$-8.13 Million ≈ $-5.76 Million	-2.102x	-109.47%
2017-12-31	AU$6.95 Million ≈ $4.92 Million	AU$-6.98 Million ≈ $-4.94 Million	-1.004x	-4289.57%
2016-12-31	AU$11.69 Million ≈ $8.27 Million	AU$-267.26K ≈ $-189.10K	-0.023x	-104.80%
2015-12-31	AU$-8.86 Million ≈ $-6.27 Million	AU$-4.22 Million ≈ $-2.99 Million	0.477x	-22.14%
2014-12-31	AU$-3.97 Million ≈ $-2.81 Million	AU$-2.43 Million ≈ $-1.72 Million	0.612x	--

About Imagion Biosystems Ltd

AU:IBX Australia Diagnostics & Research

Market Cap

$5.55 Million

AU$7.85 Million AUD

Market Cap Rank

#28362 Global

#1516 in Australia

Share Price

AU$0.02

Change (1 day)

+6.67%

52-Week Range

AU$0.01 - AU$0.05

All Time High

AU$8.60